Table 2.
Association between primary endpoint (CD4+ T cell count <350 cells/ml or commencement of long-term ART) and baseline characteristics
| Univariable unadjusted | Multivariable adjusteda | |||
|---|---|---|---|---|
| Covariate | HR (95 % CI) | Pa | HR (95 % CI) | Pb |
| CD1c + mDC count (<10 versus ≥10 cells/μL) | 6.52 (2.11–20.14) | 0.001 | 4.76 (1.40–16.18) | 0.012 |
| CD4+ T cell count (<350 versus ≥350 cells/μL) | 0.34 (0.14–0.82) | 0.016 | 0.39 (0.11–1.37) | 0.140 |
| Viral load (<5 versus ≥5 log10 copies/mL) | 1.50 (0.67–3.36) | 0.320 | 0.55 (0.14–2.10) | 0.383 |
CI confidence interval, HR hazard ratio. P-value from Wald test
P a-value is from univariable cox analyses. P b-value is from multivariable cox analyses
aResults adjusted for CD1c + mDC counts, CD4+ T cell counts, and HIV viral loads